# JCO Precision Oncology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/jco-precision-oncology/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,979 |
| h-index | 75 |
| Homepage | https://ascopubs.org/journal/po |
| Open Access | false |
| ISSN-L | 2473-4284 |
| ISSNs | 2473-4284 |
| OpenAlex ID | https://openalex.org/S4210227748 |
| Publisher | Lippincott Williams & Wilkins |
| Works | 2,077 |

## Journal papers

- [OncoKB: A Precision Oncology Knowledge Base](https://scholariq.org/papers/oncokb-a-precision-oncology-knowledge-base/)
- [Analysis of <i>NTRK</i> Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics](https://scholariq.org/papers/analysis-of-i-ntrk-i-alterations-in-pan-cancer-adult-and-pediatric-malignancies/)
- [Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/patterns-of-metastatic-spread-and-mechanisms-of-resistance-to-crizotinib-in-i/)
- [Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non–Small-Cell Lung Cancer Using a Decision Analytic Model](https://scholariq.org/papers/economic-impact-of-next-generation-sequencing-versus-single-gene-testing-to/)
- [Clinicopathologic Features of Non–Small-Cell Lung Cancer Harboring an <i>NTRK</i> Gene Fusion](https://scholariq.org/papers/clinicopathologic-features-of-non-small-cell-lung-cancer-harboring-an-i-ntrk-i/)
- [Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer](https://scholariq.org/papers/effects-of-metastatic-sites-on-circulating-tumor-dna-in-patients-with-metastatic/)
- [Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United States](https://scholariq.org/papers/disparities-in-biomarker-testing-and-clinical-trial-enrollment-among-patients/)
- [Understanding Inherited Risk in Unselected Newly Diagnosed Patients With Endometrial Cancer](https://scholariq.org/papers/understanding-inherited-risk-in-unselected-newly-diagnosed-patients-with/)
- [Nearly Half of <i>TP53</i> Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children’s Oncology Group](https://scholariq.org/papers/nearly-half-of-i-tp53-i-germline-variants-predicted-to-be-pathogenic-in-patients/)
- [Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer](https://scholariq.org/papers/multi-institution-analysis-of-tarlatamab-for-the-treatment-of-i-egfr-i-mutant/)
- [Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient Cohort](https://scholariq.org/papers/homologous-recombination-deficiency-in-skin-cancers-prevalence-and-clinical/)

## Journal top topics

Showing 8 of 25.

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.